Syngenta prepares to revive plans for IPO in Hong Kong
Chinese-owned company previously scrapped plans for listing in Shanghai
Related reading
China’s star tech companies rush to list in Hong Kong
The territory has made a series of reforms that have helped fuel an IPO boom
Hedge funds return to Hong Kong listings
Investors are coming back to the Chinese market after extended slowdown
Eli Lilly to sign $2bn deal for AI drug development with Hong Kong biotech
Global pharmaceutical companies are aggressively searching for new medicines in China
Chinese IPOs in US falter amid scrutiny of manipulation schemes
Regulators crack down after trading in ‘toxic’ small-cap stocks from China inflicted losses on US investors
Hong Kong plans to ‘name and shame’ lawyers and auditors for sloppy IPO work
Proposal comes as regulators grapple with influx of Chinese companies looking to raise funds in the city
China curbs ‘low-quality’ listings to cool Hong Kong IPO boom
Regulator targets some opaque ‘red-chip’ structures but signals the market for new issues is still open